← Back to Analyst Consensus 
MDT Buy
Medtronic plc
Current Price —
Implied Upside —
Analysts 33
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 2 reiterations from 3 firms
Next Earnings
Nov 24, 2026 (28 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 12, 2026 | BTIG | maintain | Buy → Buy | $99 | 52% |
| Oct 7, 2026 | Barclays | initiate | — → Equal-Weight | $95 | 53% |
| Sep 30, 2026 | TD Cowen | reiterate | Buy → Buy | $110 | 54% |
| Sep 3, 2026 | UBS | maintain | Buy → Buy | $110 | 54% |
| Sep 2, 2026 | Truist Securities | reiterate | Hold → Hold | $99 | 54% |
| Sep 2, 2026 | Wells Fargo | maintain | Overweight → Overweight | $104 | 54% |
| Sep 2, 2026 | RBC Capital | reiterate | Outperform → Outperform | $118 | 55% |
| Sep 2, 2026 | B of A Securities | maintain | Buy → Buy | $110 | 53% |
| Sep 2, 2026 | Stifel | maintain | Hold → Hold | $95 | 53% |
| Sep 2, 2026 | Baird | maintain | Neutral → Neutral | $100 | 55% |
| Sep 1, 2026 | BTIG | maintain | Buy → Buy | $100 | 52% |
| Sep 1, 2026 | Needham | reiterate | Buy → Buy | $114 | 50% |
| Aug 28, 2026 | TD Cowen | maintain | Buy → Buy | $110 | 54% |
| Aug 27, 2026 | Needham | maintain | Buy → Buy | $114 | 50% |
| Aug 18, 2026 | BTIG | reiterate | Buy → Buy | $91 | 52% |
| Jul 28, 2026 | UBS | upgrade | Neutral → Buy | $100 | 54% |
| Jul 10, 2026 | TD Cowen | maintain | Buy → Buy | $100 | 54% |
| Jul 6, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | $105 | 58% |
| Jun 17, 2026 | Needham | reiterate | Buy → Buy | — | 50% |
| Jun 5, 2026 | Goldman Sachs | maintain | Neutral → Neutral | $83 | 54% |
| Jun 5, 2026 | Bernstein | maintain | Outperform → Outperform | $97 | 52% |
| Jun 4, 2026 | UBS | maintain | Neutral → Neutral | $85 | 54% |
| Jun 4, 2026 | TD Cowen | reiterate | Buy → Buy | $119 | 54% |
| Jun 4, 2026 | RBC Capital | reiterate | Outperform → Outperform | $118 | 55% |
| Jun 4, 2026 | Wells Fargo | maintain | Overweight → Overweight | $102 | 54% |
| Jun 4, 2026 | Leerink Partners | maintain | Outperform → Outperform | $104 | 51% |
| Jun 4, 2026 | Baird | maintain | Neutral → Neutral | $85 | 55% |
| Jun 4, 2026 | BTIG | upgrade | Neutral → Buy | $90 | 52% |
| Jun 3, 2026 | Mizuho | maintain | Outperform → Outperform | $100 | 52% |
| Jun 3, 2026 | Needham | maintain | Buy → Buy | $101 | 50% |
| Apr 22, 2026 | UBS | maintain | Neutral → Neutral | $90 | 54% |
| Apr 15, 2026 | Truist Securities | maintain | Hold → Hold | $95 | 54% |
| Apr 13, 2026 | Mizuho | maintain | Outperform → Outperform | $120 | 52% |
| Apr 9, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | $106 | 58% |
| Apr 7, 2026 | Citigroup | maintain | Buy → Buy | $110 | 54% |
| Apr 6, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | $108 | 58% |
| Apr 6, 2026 | Argus Research | maintain | Buy → Buy | $115 | 54% |
| Apr 1, 2026 | Barclays | maintain | Overweight → Overweight | $120 | 53% |
| Apr 1, 2026 | Piper Sandler | maintain | Neutral → Neutral | $91 | 54% |
| Mar 26, 2026 | Needham | reiterate | Buy → Buy | $120 | 50% |
| Mar 10, 2026 | Needham | reiterate | Buy → Buy | $120 | 50% |
| Feb 18, 2026 | JP Morgan | maintain | Neutral → Neutral | $100 | 55% |
| Feb 18, 2026 | Barclays | maintain | Overweight → Overweight | $118 | 53% |
| Feb 18, 2026 | Baird | maintain | Neutral → Neutral | $100 | 55% |
| Feb 17, 2026 | Needham | maintain | Buy → Buy | $120 | 50% |
| Feb 9, 2026 | Needham | upgrade | Hold → Buy | $121 | 50% |
| Feb 4, 2026 | UBS | maintain | Neutral → Neutral | $104 | 54% |
| Jan 9, 2026 | Bernstein | maintain | Outperform → Outperform | $112 | 52% |
| Jan 8, 2026 | Barclays | maintain | Overweight → Overweight | $116 | 53% |
| Jan 6, 2026 | William Blair | upgrade | Market Perform → Outperform | $0 | 48% |
Price Target Trend
Aug 24, 2026 Oct 27, 2026
EPS Estimates
0q —
0y —
+1q —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days